Back
Moleculin Biotech Vs. Dave Industry Stock Comparison
Sell
17
MBRX
Moleculin Biotech
Last Price:
$1.26
Seasonality Move:
-10.9%
Buy
67
DAVE
Dave
Last Price:
$86.07
Seasonality Move:
-3.93%
Sell
17
Moleculin Biotech (MBRX)
is a Sell
Is Moleculin Biotech a Buy, Sell or Hold?
-
The current Moleculin Biotech [MBRX] share price is $1.19. The Score for MBRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
MBRX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
MBRX Stock Price Chart
What is Moleculin Biotech's stock price today?
-
The Moleculin Biotech share price today is $1.19The current trend is relatively stagnant and MBRX is experiencing slight buying pressure.
DAVE Stock Price Chart
MBRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 47.12 | Sell |
Chaikin Money Flow: | 308072 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.81 - 1.57) | Sell |
Bollinger Bands (100): | (1.36 - 2.58) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.4 | Sell |
Relative Strength Index (14 RSI): | 35.37 | Sell |
Chaikin Money Flow: | -191798 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (90.86 - 110.32) | Sell |
Bollinger Bands (100): | (59.34 - 103.9) | Buy |
MBRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.17 | Buy |
20-day SMA: | 1.22 | Sell |
50-day SMA: | 1.46 | Sell |
200-day SMA: | 2.6 | Sell |
8-day EMA: | 1.17 | Buy |
20-day EMA: | 1.24 | Sell |
50-day EMA: | 1.49 | Sell |
200-day EMA: | 2.94 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.36 | Sell |
20-day SMA: | 100.85 | Sell |
50-day SMA: | 95.49 | Sell |
200-day SMA: | 59.5 | Buy |
8-day EMA: | 89.51 | Sell |
20-day EMA: | 95.46 | Sell |
50-day EMA: | 93.47 | Sell |
200-day EMA: | 66.68 | Buy |
Moleculin Biotech Earnings Growth & MBRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.81 per share, and an increase next year of $0.43 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.83 per share, an increase next quarter of $0.09 per share, an increase this year of $1.90 per share, and an increase next year of $0.79 per share.
Moleculin Biotech Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |